246 related articles for article (PubMed ID: 23973197)
1. Short-term glucose metabolism and gut hormone modulations after Billroth II gastrojejunostomy in nonobese gastric cancer patients with type 2 diabetes mellitus, impaired glucose tolerance and normal glucose tolerance.
Zhang XJ; Xiao Z; Yu HL; Zhang XX; Cheng Z; Tian HM
Arch Med Res; 2013 Aug; 44(6):437-43. PubMed ID: 23973197
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Short- and Mid-term Efficacy and the Mechanisms of Gastric Bypass Surgeries on Managing Obese and Nonobese Type 2 Diabetes Mellitus: A Prospective Study.
Zhang X; Cheng Z; Xiao Z; Du X; Du J; Li Y; Long Y; Yu H; Zhang X; Tian H
Arch Med Res; 2015 May; 46(4):303-9. PubMed ID: 26087171
[TBL] [Abstract][Full Text] [Related]
3. A randomized controlled trial of Roux-en-Y gastrojejunostomy vs. gastroduodenostomy with respect to the improvement of type 2 diabetes mellitus after distal gastrectomy in gastric cancer patients.
Choi YY; Noh SH; An JY
PLoS One; 2017; 12(12):e0188904. PubMed ID: 29216250
[TBL] [Abstract][Full Text] [Related]
4. GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects.
Morínigo R; Lacy AM; Casamitjana R; Delgado S; Gomis R; Vidal J
Obes Surg; 2006 Dec; 16(12):1594-601. PubMed ID: 17217635
[TBL] [Abstract][Full Text] [Related]
5. EndoBarrier gastrointestinal liner. Delineation of underlying mechanisms and clinical effects.
Rohde U
Dan Med J; 2016 Nov; 63(11):. PubMed ID: 27808040
[TBL] [Abstract][Full Text] [Related]
6. Impact of incretin on early-phase insulin secretion and glucose excursion.
Shen J; Chen Z; Chen C; Zhu X; Han Y
Endocrine; 2013 Oct; 44(2):403-10. PubMed ID: 23283820
[TBL] [Abstract][Full Text] [Related]
7. Roux-en-Y gastric bypass compared with equivalent diet restriction: Mechanistic insights into diabetes remission.
Pop LM; Mari A; Zhao TJ; Mitchell L; Burgess S; Li X; Adams-Huet B; Lingvay I
Diabetes Obes Metab; 2018 Jul; 20(7):1710-1721. PubMed ID: 29532631
[TBL] [Abstract][Full Text] [Related]
8. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.
Nannipieri M; Baldi S; Mari A; Colligiani D; Guarino D; Camastra S; Barsotti E; Berta R; Moriconi D; Bellini R; Anselmino M; Ferrannini E
J Clin Endocrinol Metab; 2013 Nov; 98(11):4391-9. PubMed ID: 24057293
[TBL] [Abstract][Full Text] [Related]
9. Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes.
Rhee NA; Wahlgren CD; Pedersen J; Mortensen B; Langholz E; Wandall EP; Friis SU; Vilmann P; Paulsen SJ; Kristiansen VB; Jelsing J; Dalbøge LS; Poulsen SS; Holst JJ; Vilsbøll T; Knop FK
Diabetologia; 2015 Oct; 58(10):2254-8. PubMed ID: 26186884
[TBL] [Abstract][Full Text] [Related]
10. Impact of the different biliopancreatic limb length on diabetes and incretin hormone secretion following distal gastrectomy in gastric cancer patients.
Park JY; Kwon OK; Jeon JH; Choi YK; Park KB
Sci Rep; 2021 Nov; 11(1):22451. PubMed ID: 34789863
[TBL] [Abstract][Full Text] [Related]
11. Calorie restriction is a major determinant of the short-term metabolic effects of gastric bypass surgery in obese type 2 diabetic patients.
Lips MA; de Groot GH; van Klinken JB; Aarts E; Berends FJ; Janssen IM; Van Ramshorst B; Van Wagensveld BA; Swank DJ; Van Dielen F; Willems van Dijk K; Pijl H
Clin Endocrinol (Oxf); 2014 Jun; 80(6):834-42. PubMed ID: 23711328
[TBL] [Abstract][Full Text] [Related]
12. The effect of selective gut stimulation on glucose metabolism after gastric bypass in the Zucker diabetic fatty rat model.
Shimizu H; Eldar S; Heneghan HM; Schauer PR; Kirwan JP; Brethauer SA
Surg Obes Relat Dis; 2014; 10(1):29-35. PubMed ID: 23507630
[TBL] [Abstract][Full Text] [Related]
13. Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance.
Rask E; Olsson T; Söderberg S; Holst Jj Jj; Tura A; Pacini G; Ahrén B
Metabolism; 2004 May; 53(5):624-31. PubMed ID: 15131768
[TBL] [Abstract][Full Text] [Related]
14. The difference of glucostatic parameters according to the remission of diabetes after Roux-en-Y gastric bypass.
Kim MK; Lee HC; Lee SH; Kwon HS; Baek KH; Kim EK; Lee KW; Song KH
Diabetes Metab Res Rev; 2012 Jul; 28(5):439-46. PubMed ID: 22407971
[TBL] [Abstract][Full Text] [Related]
15. Metabolic responses to xenin-25 are altered in humans with Roux-en-Y gastric bypass surgery.
Sterl K; Wang S; Oestricker L; Wallendorf MJ; Patterson BW; Reeds DN; Wice BM
Peptides; 2016 Aug; 82():76-84. PubMed ID: 27288245
[TBL] [Abstract][Full Text] [Related]
16. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.
Jacobsen SH; Olesen SC; Dirksen C; Jørgensen NB; Bojsen-Møller KN; Kielgast U; Worm D; Almdal T; Naver LS; Hvolris LE; Rehfeld JF; Wulff BS; Clausen TR; Hansen DL; Holst JJ; Madsbad S
Obes Surg; 2012 Jul; 22(7):1084-96. PubMed ID: 22359255
[TBL] [Abstract][Full Text] [Related]
17. Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes.
Kashyap SR; Daud S; Kelly KR; Gastaldelli A; Win H; Brethauer S; Kirwan JP; Schauer PR
Int J Obes (Lond); 2010 Mar; 34(3):462-71. PubMed ID: 20029383
[TBL] [Abstract][Full Text] [Related]
18. The impact of EndoBarrier gastrointestinal liner in obese patients with normal glucose tolerance and in patients with type 2 diabetes.
Rohde U; Federspiel CA; Vilmann P; Langholz E; Friis SU; Krakauer M; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK
Diabetes Obes Metab; 2017 Feb; 19(2):189-199. PubMed ID: 27696668
[TBL] [Abstract][Full Text] [Related]
19. Preserved Insulin Secretory Capacity and Weight Loss Are the Predominant Predictors of Glycemic Control in Patients With Type 2 Diabetes Randomized to Roux-en-Y Gastric Bypass.
Nguyen KT; Billington CJ; Vella A; Wang Q; Ahmed L; Bantle JP; Bessler M; Connett JE; Inabnet WB; Thomas A; Ikramuddin S; Korner J
Diabetes; 2015 Sep; 64(9):3104-10. PubMed ID: 25901097
[TBL] [Abstract][Full Text] [Related]
20. Older Subjects With β-Cell Dysfunction Have an Accentuated Incretin Release.
de Jesús Garduno-Garcia J; Gastaldelli A; DeFronzo RA; Lertwattanarak R; Holst JJ; Musi N
J Clin Endocrinol Metab; 2018 Jul; 103(7):2613-2619. PubMed ID: 29672742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]